Powered by

Hancock Jaffe Updates Status of Application to INVIMA for First-In-Human VenoValve Trial in Colombia

Nov 20, 2018 - GlobeNewswire

IRVINE, Calif., Nov. 20, 2018 (GLOBE NEWSWIRE) -- Hancock Jaffe Laboratories, Inc. (Nasdaq: HJLI, HJLIW), a company specializing in medical devices that restore cardiac and vascular health, announced today that it has received an update from INVIMA (the Colombian equivalent of the U.S. FDA) in Bogota on the status of Hancock Jaffe's application for its first-in-human trial for the VenoValveĀ®.Ā  INVIMA officials confirmed that its members have completed their review of the Hancock Jaffe applic...